| Name: | Aripiprazole Butanoic Acid Impurity |
| Catalogue No. | VL197022 |
| CAS No. | 58899-27-7 |
| Molecular Formula | C13H15NO4 |
| Molecular Weight | 249.26 |
| Status | In-stock |
| IUPAC Name | 4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butanoic acid |
| Appearance | Off White Powder |
| Description | Aripiprazole Butanoic Acid Impurity(CAS No: N/A) or 4-[(1,2,3,4-Tetrahydro-2-oxo-7-quinolinyl)oxy]-butanoic Acid, has a class of an atypical antipsychotic which is used to treatment of schizophrenia and schizoaffective disorder. |
| References | Arıkan, Mehmet Kemal, et al. “Gamma Oscillations Predict Treatment Response to Aripiprazole in Bipolar Disorder.” Journal of Affective Disorders, vol. 294, Nov. 2021, pp. 159–62, https://doi.org/10.1016/j.jad.2021.07.044. |
![Aripiprazole(N-3-(hydroxyphenyl)-3[(2-oxo-1H-quinoline-7-yl)oxy]propanamide)](/public/site/files/site_images/thumb_aripiprazole-n-3-hydroxyphenyl-3-2-oxo-1h-quinoline-7-yl-oxy-propanamide64113.png)
![Di-[2-(2,3-dichlorophenyl)aminoethyl]amine](/public/site/files/site_images/thumb_di-2-2-3-dichlorophenyl-aminoethyl-amine73090.png)
